Azithromycin versus doxycycline: management of female urogenital and rectal Chlamydia trachomatis infections

N Z Med J. 2022 Oct 7;135(1563):108-110. doi: 10.26635/6965.5715.

Authors

Elissa M McDonald¹, Rachel T Woodcock², Felix F S Ram³

Affiliations

¹ Massey University, Albany Campus, Auckland, New Zealand.
² Registered Nurse, Family Planning, Newmarket, Auckland, New Zealand.
³ Director, Centre of Excellence for Person-Centred Aged-Care, Oceania HealthCare, Auckland, New Zealand.

PMID: 36201736
DOI: 10.26635/6965.5715

Abstract

Nil.

© PMA.

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
Azithromycin* / therapeutic use
Chlamydia Infections* / drug therapy
Chlamydia trachomatis
Doxycycline / therapeutic use
Female
Humans
New Zealand

Substances

Anti-Bacterial Agents
Azithromycin
Doxycycline